ArticleMolecular cancer therapeutics2020

Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma.

Melanie A Krook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.